116 related articles for article (PubMed ID: 36822174)
1. LncRNA15691 promotes T-ALL infiltration by upregulating CCR9 via increased MATR3 stability.
Zeng X; Lei Y; Pan S; Sun J; He H; Xiao D; Jamal M; Shen H; Zhou F; Shao L; Zhang Q
J Leukoc Biol; 2023 Feb; 113(2):203-215. PubMed ID: 36822174
[TBL] [Abstract][Full Text] [Related]
2. LINC00853 restrains T cell acute lymphoblastic leukemia invasion and infiltration by regulating CCR9/CCL25.
Li J; Muhammad J; Xie T; Sun J; Lei Y; Wei Z; Pan S; Qin H; Shao L; Jiang D; Zhang Q
Mol Immunol; 2021 Dec; 140():267-275. PubMed ID: 34808497
[TBL] [Abstract][Full Text] [Related]
3. Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia.
Mirandola L; Chiriva-Internati M; Montagna D; Locatelli F; Zecca M; Ranzani M; Basile A; Locati M; Cobos E; Kast WM; Asselta R; Paraboschi EM; Comi P; Chiaramonte R
J Pathol; 2012 Apr; 226(5):713-22. PubMed ID: 21984373
[TBL] [Abstract][Full Text] [Related]
4. CCR9 overexpression promotes T-ALL progression by enhancing cholesterol biosynthesis.
Jamal M; Lei Y; He H; Zeng X; Bangash HI; Xiao D; Shao L; Zhou F; Zhang Q
Front Pharmacol; 2023; 14():1257289. PubMed ID: 37745085
[No Abstract] [Full Text] [Related]
5. RNA-Binding Proteomics Reveals MATR3 Interacting with lncRNA SNHG1 To Enhance Neuroblastoma Progression.
Yang TW; Sahu D; Chang YW; Hsu CL; Hsieh CH; Huang HC; Juan HF
J Proteome Res; 2019 Jan; 18(1):406-416. PubMed ID: 30516047
[TBL] [Abstract][Full Text] [Related]
6. Wnt5a and CCL25 promote adult T-cell acute lymphoblastic leukemia cell migration, invasion and metastasis.
Deng X; Tu Z; Xiong M; Tembo K; Zhou L; Liu P; Pan S; Xiong J; Yang X; Leng J; Zhang Q; Xiao R; Zhang Q
Oncotarget; 2017 Jun; 8(24):39033-39047. PubMed ID: 28380463
[TBL] [Abstract][Full Text] [Related]
7. Chemotactic Cues for NOTCH1-Dependent Leukemia.
Piovan E; Tosello V; Amadori A; Zanovello P
Front Immunol; 2018; 9():633. PubMed ID: 29666622
[TBL] [Abstract][Full Text] [Related]
8. Specific killing of CCR9 high-expressing acute T lymphocytic leukemia cells by CCL25 fused with PE38 toxin.
Hu Y; Zhang L; Wu R; Han R; Jia Y; Jiang Z; Cheng M; Gan J; Tao X; Zhang Q
Leuk Res; 2011 Sep; 35(9):1254-60. PubMed ID: 21295855
[TBL] [Abstract][Full Text] [Related]
9. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.
Johnson EL; Singh R; Singh S; Johnson-Holiday CM; Grizzle WE; Partridge EE; Lillard JW
World J Surg Oncol; 2010 Jul; 8():62. PubMed ID: 20649989
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9
Santamaria S; Delgado M; Botas M; Castellano E; Corraliza-Gorjon I; Lafuente P; Muñoz-Calleja C; Toribio ML; Kremer L; Garcia-Sanz JA
Front Immunol; 2022; 13():825635. PubMed ID: 35967322
[TBL] [Abstract][Full Text] [Related]
11. Activated ERM protein plays a critical role in drug resistance of MOLT4 cells induced by CCL25.
Zhang L; Xiao R; Xiong J; Leng J; Ehtisham A; Hu Y; Ding Q; Xu H; Liu S; Wang J; Tang DG; Zhang Q
PLoS One; 2013; 8(1):e52384. PubMed ID: 23326330
[TBL] [Abstract][Full Text] [Related]
12. Role of CXCR4-mediated bone marrow colonization in CNS infiltration by T cell acute lymphoblastic leukemia.
Jost TR; Borga C; Radaelli E; Romagnani A; Perruzza L; Omodho L; Cazzaniga G; Biondi A; Indraccolo S; Thelen M; Te Kronnie G; Grassi F
J Leukoc Biol; 2016 Jun; 99(6):1077-87. PubMed ID: 26931577
[TBL] [Abstract][Full Text] [Related]
13. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.
Apostolaki M; Manoloukos M; Roulis M; Wurbel MA; Müller W; Papadakis KA; Kontoyiannis DL; Malissen B; Kollias G
Gastroenterology; 2008 Jun; 134(7):2025-35. PubMed ID: 18439426
[TBL] [Abstract][Full Text] [Related]
14. CCL25/CCR9 interaction promotes the malignant behavior of salivary adenoid cystic carcinoma
Chai S; Wen Z; Zhang R; Bai Y; Liu J; Li J; Kongling W; Chen W; Wang F; Gao L
PeerJ; 2022; 10():e13844. PubMed ID: 36003306
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis.
Abd Alla J; Langer A; Elzahwy SS; Arman-Kalcek G; Streichert T; Quitterer U
J Biol Chem; 2010 Jul; 285(30):23496-505. PubMed ID: 20504763
[TBL] [Abstract][Full Text] [Related]
16. CC chemokine ligand 25 enhances resistance to apoptosis in CD4+ T cells from patients with T-cell lineage acute and chronic lymphocytic leukemia by means of livin activation.
Qiuping Z; Jei X; Youxin J; Wei J; Chun L; Jin W; Qun W; Yan L; Chunsong H; Mingzhen Y; Qingping G; Kejian Z; Zhimin S; Qun L; Junyan L; Jinquan T
Cancer Res; 2004 Oct; 64(20):7579-87. PubMed ID: 15492285
[TBL] [Abstract][Full Text] [Related]
17. Possible link between unique chemokine and homing receptor expression at diagnosis and relapse location in a patient with childhood T-ALL.
Annels NE; Willemze AJ; van der Velden VH; Faaij CM; van Wering E; Sie-Go DM; Egeler RM; van Tol MJ; Révész T
Blood; 2004 Apr; 103(7):2806-8. PubMed ID: 14656893
[TBL] [Abstract][Full Text] [Related]
18. Selectively increased expression and functions of chemokine receptor CCR9 on CD4+ T cells from patients with T-cell lineage acute lymphocytic leukemia.
Qiuping Z; Qun L; Chunsong H; Xiaolian Z; Baojun H; Mingzhen Y; Chengming L; Jinshen H; Qingping G; Kejian Z; Zhimin S; Xuejun Z; Junyan L; Jinquan T
Cancer Res; 2003 Oct; 63(19):6469-77. PubMed ID: 14559839
[TBL] [Abstract][Full Text] [Related]
19. Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation.
Schmutz C; Cartwright A; Williams H; Haworth O; Williams JH; Filer A; Salmon M; Buckley CD; Middleton J
Arthritis Res Ther; 2010; 12(4):R161. PubMed ID: 20738854
[TBL] [Abstract][Full Text] [Related]
20. CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion.
Johnson-Holiday C; Singh R; Johnson E; Singh S; Stockard CR; Grizzle WE; Lillard JW
Int J Oncol; 2011 May; 38(5):1279-85. PubMed ID: 21344163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
